Similarly, analysis of the bone marrow (BM) immune microenvironment in B-ALL showed increased expression of TIGIT, LAG3, and PD-1 on CD4+ and CD8+ T cells compared to healthy controls (63). The gene discussed is TIGIT; the disease is precursor B-cell acute lymphoblastic leukemia.